Tuberculosis: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

No stopped trial with a stated reason in this view.

Trials whose registry record says individual participant data (IPD) will be shared.

• PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia

  NCT04926922· National Institute of Allergy and Infectious Diseases (NIAID)· Source

• Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients

  NCT03568383· National Institute of Allergy and Infectious Diseases (NIAID)· Source

• A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV

  NCT07124559· National Institute of Allergy and Infectious Diseases (NIAID)· Source

• Pharmacokinetics of Antituberculosis Drugs in Breastfeeding Women

  NCT07069582· McGill University Health Centre/Research Institute of the McGill University Health Centre· Source

• Re-evaluating the Duration in Children of TB Treatment

  NCT07656012· University of Wisconsin, Madison· Source

• Mycobacterial and Opportunistic Infections in HIV-Negative Thai and Taiwanese Patients Associated With Autoantibodies to Interferon-gamma

  NCT00814827· National Institute of Allergy and Infectious Diseases (NIAID)· Source

• A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis

  NCT07209761· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

• Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)

  NCT07163143· University College, London· Source

• A Phase 1 Multiple Dose Trial in Healthy Adult Participants to Evaluate the Safety, Tolerability, Drug-Drug Interactions, and Pharmacokinetics of TBD11

  NCT07883226· Gates Medical Research Institute· Source

• Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB

  NCT06568484· Johns Hopkins University· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Gene Expression Profiling 8
• Sequence Analysis, RNA 1
• Whole Genome Sequencing 2
• Proteomics 1
• Metabolomics 1
• Mass Spectrometry 2
• Flow Cytometry 6
• Immunohistochemistry 3
• Magnetic Resonance Imaging 1
• Cohort Studies 22
• Genome-Wide Association Study 1

• Molecular Mechanisms of Tibetan Medicinal Sea Buckthorn in the Treatment of Pulmonary Diseases: An Integrated Analysis of Network Pharmacology and Transcriptomics.

  Int J Mol Sci, Jul 2026

• Insights into the host response to 'dormant' Mycobacterium tuberculosis utilizing 'Vitamin C-induced dormant Mtb' THP-1 cell infection model.

  BMC Genomics, Jan 2026

• Zinc pyrithione impairs iron-sulfur cluster biogenesis in Mycobacterium tuberculosis.

  BMC Microbiol, Dec 2025

• A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.

  Front Immunol, Dec 2020

• Polarization of Human Monocyte-Derived Cells With Vitamin D Promotes Control of Mycobacterium tuberculosis Infection.

  Front Immunol, Jan 2020

• Zinc finger and interferon-stimulated genes play a vital role in TB-IRIS following HAART in AIDS.

  Per Med, Jul 2018

• Genome-wide expression profiling establishes novel modulatory roles of vitamin C in THP-1 human monocytic cell line.

  BMC Genomics, Mar 2017

• The pleiotropic transcriptional response of Mycobacterium tuberculosis to vitamin C is robust and overlaps with the bacterial response to multiple intracellular stresses.

  Microbiology (Reading), Feb 2015

See which targets of this disease your abstract mentions, and go to the people working on them.